Cancer incidence and mortality rates and trends in Trinidad and Tobago
Date
2018-07-04
Authors
Warner, Wayne A
Lee, Tammy Y
Badal, Kimberly
Williams, Tanisha M
Bajracharya, Smriti
Sundaram, Vasavi
Bascombe, Nigel A
Maharaj, Ravi
Lamont-Greene, Marjorie
Roach, Allana
Journal Title
Journal ISSN
Volume Title
Publisher
Abstract
Abstract
Background
Cancer is the second leading cause of death in the Caribbean, including the islands of Trinidad and Tobago (TT). The population of TT consists of over 1.3 million people with diverse ancestral and sociocultural backgrounds, both of which may influence cancer incidence and mortality. The objective of this study was to examine incidence and mortality patterns and trends in TT.
Methods
Cancer surveillance data on 29,512 incident cancer cases reported to the Dr. Elizabeth Quamina Cancer Registry (population-based cancer registry of TT) between 1995 and 2009 were analyzed. Age-standardized rates, overall and by sex, ancestry, and geography, were reported.
Results
The highest incidence and mortality rates were observed for cancers related to reproductive organs in women, namely, breast, cervical, and uterine cancers, and prostate, lung and colorectal cancers among men. Average incidence rates were highest in areas covered by the Tobago Regional Health Authority (TRHA) (188 per 100,000), while average mortality rates were highest in areas covered by the North West Regional Health Authority (108 per 100,000). Nationals of African ancestry exhibited the highest rates of cancer incidence (243 per 100,000) and mortality (156 per 100,000) compared to their counterparts who were of East Indian (incidence, 125 per 100,000; mortality, 66 per 100,000) or mixed ancestry (incidence, 119 per 100,000; mortality, 66 per 100,000).
Conclusions
Our findings highlight the need for national investment to improve the understanding of the epidemiology of cancer in Trinidad and Tobago, and to ultimately guide much needed cancer prevention and control initiatives in the near future.
Description
Table of Contents
Keywords
Citation
BMC Cancer. 2018 Jul 04;18(1):712